{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:33:41Z","timestamp":1788572021337,"version":"build-2803163510"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU Third Health Programme","award":["709844"],"award-info":[{"award-number":["709844"]}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University College London Hospitals NHS Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>HCV infection disproportionately affects underserved populations such as homeless individuals, people who inject drugs and prison populations. Peer advocacy can enable active engagement with healthcare services and increase the likelihood of favourable treatment outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This observational study aims to assess the burden of disease in these underserved populations and describe the role of peer support in linking these individuals to specialist treatment services.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Services were identified if they had a high proportion of individuals with risk factors for HCV, such as injecting drug use or homelessness. Individuals were screened for HCV using point-of-care tests and a portable FibroScan. All positive cases received peer support for linkage to specialist care. Information was gathered on risk factors, demographics and follow-up information regarding linkage to care and treatment outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 461 individuals were screened, of which 197 (42.7%) were chronically infected with HCV. Referral was made to secondary care for 176 (89.3%) and all received peer support, with 104 (52.8%) individuals engaged with treatment centres. Of these, 89 (85.6%) started treatment and 76 (85.4%) had a favourable outcome. Factors associated with not being approved for treatment were recent homelessness, younger age and current crack cocaine injecting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Highly trained peer support workers working as part of a specialist outreach clinical team help to identify a high proportion of individuals exposed to HCV, achieve high rates of engagement with treatment services and maintain high rates of treatment success amongst a population with complex needs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkz452","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T16:09:41Z","timestamp":1572451781000},"page":"v17-v23","source":"Crossref","is-referenced-by-count":43,"title":["From peer-based to peer-led: redefining the role of peers across the hepatitis C care pathway: HepCare Europe"],"prefix":"10.1093","volume":"74","author":[{"given":"Julian","family":"Surey","sequence":"first","affiliation":[{"name":"Institute of Global Health, University College London, London, UK"},{"name":"Find and Treat, University College London Hospitals NHS Trust, London, UK"},{"name":"Universidad Aut\u00f3noma de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dee","family":"Menezes","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Francis","sequence":"additional","affiliation":[{"name":"Institute of Global Health, University College London, London, UK"},{"name":"Find and Treat, University College London Hospitals NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gibbons","sequence":"additional","affiliation":[{"name":"Find and Treat, University College London Hospitals NHS Trust, London, UK"},{"name":"Groundswell, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binta","family":"Sultan","sequence":"additional","affiliation":[{"name":"Institute of Global Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Miah","sequence":"additional","affiliation":[{"name":"Groundswell, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abubakar","sequence":"additional","affiliation":[{"name":"Institute of Global Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Story","sequence":"additional","affiliation":[{"name":"Find and Treat, University College London Hospitals NHS Trust, London, UK"},{"name":"Collaborative Centre for Inclusion Health, UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"2019112905303432600_dkz452-B1"},{"key":"2019112905303432600_dkz452-B2"},{"key":"2019112905303432600_dkz452-B3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int J Med Sci"},{"key":"2019112905303432600_dkz452-B4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.drugpo.2007.01.009","article-title":"Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection","volume":"18","author":"Grebely","year":"2007","journal-title":"Int J Drug Policy"},{"key":"2019112905303432600_dkz452-B5","doi-asserted-by":"crossref","first-page":"2.","DOI":"10.1186\/s41124-016-0011-y","article-title":"Urgent action to fight hepatitis C in people who inject drugs in Europe","volume":"1","author":"Dillon","year":"2016","journal-title":"Hepatol Med Policy"},{"key":"2019112905303432600_dkz452-B6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/thoraxjnl-2016-209579","article-title":"High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population","volume":"73","author":"Aldridge","year":"2018","journal-title":"Thorax"},{"key":"2019112905303432600_dkz452-B7","doi-asserted-by":"crossref","first-page":"71.","DOI":"10.1186\/s12916-019-1300-2","article-title":"Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention","volume":"17","author":"Stagg","year":"2019","journal-title":"BMC Med"},{"key":"2019112905303432600_dkz452-B8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/bmj.317.7159.671","article-title":"Community based approaches to the control of multidrug resistant tuberculosis: introducing \u2018DOTS-plus\u2019","volume":"317","author":"Farmer","year":"1998","journal-title":"BMJ"},{"key":"2019112905303432600_dkz452-B9","doi-asserted-by":"crossref","first-page":"d5376.","DOI":"10.1136\/bmj.d5376","article-title":"Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation","volume":"343","author":"Jit","year":"2011","journal-title":"BMJ"},{"key":"2019112905303432600_dkz452-B10","doi-asserted-by":"crossref","first-page":"e0141122.","DOI":"10.1371\/journal.pone.0141122","article-title":"Peer support workers in health: a qualitative metasynthesis of their experiences","volume":"10","author":"MacLellan","year":"2015","journal-title":"PLoS One"},{"key":"2019112905303432600_dkz452-B11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/01612841003793049","article-title":"Peer support among inpatients in an adult mental health setting","volume":"31","author":"Bouchard","year":"2010","journal-title":"Issues Ment Health Nurs"},{"key":"2019112905303432600_dkz452-B12","doi-asserted-by":"crossref","first-page":"188.","DOI":"10.1186\/1472-6963-13-188","article-title":"Introducing peer worker roles into UK mental health service teams: a qualitative analysis of the organisational benefits and challenges","volume":"13","author":"Gillard","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"2019112905303432600_dkz452-B13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02287510","article-title":"Consumers as mental health providers: first-person accounts of benefits and limitations","volume":"25","author":"Mowbray","year":"1998","journal-title":"J Behav Health Serv Res"},{"key":"2019112905303432600_dkz452-B14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/her\/cyt004","article-title":"Evaluation of a peer-led hypertension intervention for veterans: impact on peer leaders","volume":"28","author":"Mosack","year":"2013","journal-title":"Health Educ Res"},{"key":"2019112905303432600_dkz452-B15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/fampra\/cmt027","article-title":"Implementing a peer-support intervention for people with type 2 diabetes: a qualitative study","volume":"30","author":"Paul","year":"2013","journal-title":"Fam Pract"},{"key":"2019112905303432600_dkz452-B16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5588\/ijtld.13.0309","article-title":"Tuberculosis peer educators: personal experiences of working with socially excluded communities in London","volume":"17","author":"Croft","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019112905303432600_dkz452-B17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/apc.2010.0388","article-title":"Positive Examples\u2019: a bottom-up approach to identifying best practices in HIV care and treatment based on the experiences of peer educators","volume":"25","author":"Dutcher","year":"2011","journal-title":"AIDS Patient Care STDS"},{"key":"2019112905303432600_dkz452-B18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1300\/J010v45n01_05","article-title":"Peer support to promote medication adherence among people living with HIV\/AIDS: the benefits to peers","volume":"45","author":"Marino","year":"2007","journal-title":"Social Work Health Care"},{"key":"2019112905303432600_dkz452-B19","doi-asserted-by":"crossref","first-page":"8.","DOI":"10.1186\/1477-7517-5-8","article-title":"The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users","volume":"5","author":"Norman","year":"2008","journal-title":"Harm Reduct J"},{"key":"2019112905303432600_dkz452-B20","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/cid\/cit297","article-title":"Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection","volume":"57","author":"Crawford","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019112905303432600_dkz452-B21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MEG.0b013e32832a8c4c","article-title":"Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support","volume":"22","author":"Grebely","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2019112905303432600_dkz452-B22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.drugpo.2015.07.005","article-title":"Recommendations for the management of hepatitis C virus infection among people who inject drugs","volume":"26","author":"Grebely","year":"2015","journal-title":"Int J Drug Policy"},{"key":"2019112905303432600_dkz452-B23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/COH.0b013e32834bcb36","article-title":"Management of HCV and HIV infections among people who inject drugs","volume":"6","author":"Grebely","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"2019112905303432600_dkz452-B24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugpo.2017.08.004","article-title":"\u2018Beyond the willing & the waiting\u2019\u2014the role of peer-based approaches in hepatitis C diagnosis & treatment","volume":"50","author":"Henderson","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2019112905303432600_dkz452-B25","first-page":"15","article-title":"Hepatitis infection in the treatment of opioid dependence and abuse","volume":"1","author":"Kresina","year":"2008","journal-title":"Subst Abuse"},{"key":"2019112905303432600_dkz452-B26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"Mehta","year":"2008","journal-title":"J Community Health"},{"key":"2019112905303432600_dkz452-B27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.drugpo.2015.01.005","article-title":"Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: the ETHOS study, Australia","volume":"26","author":"Treloar","year":"2015","journal-title":"Int J Drug Policy"},{"key":"2019112905303432600_dkz452-B28","doi-asserted-by":"crossref","first-page":"5.","DOI":"10.1186\/1471-2296-14-5","article-title":"Testing a peer support intervention for people with type 2 diabetes: a pilot for a randomised controlled trial","volume":"14","author":"Simmons","year":"2013","journal-title":"BMC Fam Pract"},{"key":"2019112905303432600_dkz452-B29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.drugpo.2015.07.006","article-title":"Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia","volume":"26","author":"Keats","year":"2015","journal-title":"Int J Drug Policy"},{"key":"2019112905303432600_dkz452-B30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.drugpo.2017.05.031","article-title":"Tensions in relation: how peer support is experienced and received in a hepatitis C treatment intervention","volume":"47","author":"Bonnington","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2019112905303432600_dkz452-B31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","article-title":"Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis","volume":"391","author":"Aldridge","year":"2018","journal-title":"Lancet"},{"key":"2019112905303432600_dkz452-B32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2468-1253(17)30284-4","article-title":"Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe","volume":"3","author":"Marshall","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2019112905303432600_dkz452-B33","doi-asserted-by":"crossref","first-page":"994.","DOI":"10.1186\/s12889-016-3671-z","article-title":"Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals","volume":"16","author":"Rich","year":"2016","journal-title":"BMC Public Health"},{"key":"2019112905303432600_dkz452-B34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.idc.2018.02.001","article-title":"Treatment of chronic hepatitis C in patients receiving opioid agonist therapy: a review of best practice","volume":"32","author":"Norton","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"2019112905303432600_dkz452-B35","author":"Story"},{"key":"2019112905303432600_dkz452-B36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jvh.12513","article-title":"Finding the undiagnosed: a qualitative exploration of hepatitis C diagnosis delay in the United Kingdom","volume":"23","author":"Harris","year":"2016","journal-title":"J Viral Hepat"},{"key":"2019112905303432600_dkz452-B37","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.drugpo.2015.05.004","article-title":"Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries","volume":"26","author":"Ford","year":"2015","journal-title":"Int J Drug Policy"},{"key":"2019112905303432600_dkz452-B38","article-title":"The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK","volume":"74 Suppl 5","author":"Ward","year":"2019","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/Supplement_5\/v17\/31153801\/dkz452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/Supplement_5\/v17\/31153801\/dkz452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T05:30:55Z","timestamp":1575005455000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/Supplement_5\/v17\/5645637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":38,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2019,11,29]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz452","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,11,1]]}}}